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Abstract
Low levels of the Survival Motor Neuron (SMN) protein produce Spinal Muscular Atrophy (SMA), a severe monogenetic
disease in infants characterized by muscle weakness and impaired synaptic transmission. We report here severe structural
and functional alterations in the organization of the organelles and the cytoskeleton of motor nerve terminals in a mouse
model of SMA. The decrease in SMN levels resulted in the clustering of synaptic vesicles (SVs) and Active Zones (AZs),
reduction in the size of the readily releasable pool (RRP), and the recycling pool (RP) of synaptic vesicles, a decrease in active
mitochondria and limiting of neurofilament and microtubule maturation. We propose that SMN is essential for the normal
postnatal maturation of motor nerve terminals and that SMN deficiency disrupts the presynaptic organization leading to
neurodegeneration.
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Introduction
SMN (Survival Motor Neuron) is a protein that participates in
the assembly of small nuclear ribonucleoproteins (snRNPs)
[1,2,3,4]. SMN is encoded by two genes, SMN1 that produces
Full-Length SMN (SMN-FL), and SMN2 that produces a
truncated form of SMN (SMND7) and a small amount of SMN-
FL [5,6,7]. Spinal Muscular Atrophy (SMA), a severe autosomal
recessive genetic disease in infants characterized by motor
impairment and premature lethality [8], caused by mutations or
loss of SMN1 and retention of SMN2 [9]. The severity of the
disease depends on the amount of SMN-FL produced by SMN2.
SMN is expressed ubiquitously, nevertheless, abnormally low
levels of SMN mainly affect motor neurons innervating proximal
muscles, however the specific role of SMN in motor neurons
remains unknown. Two main hypothesis have been postulated,
first SMN deficiency is proposed to disturb relevant RNA
processing in motor neurons [4,10,11,12,13,14,15,16]; second,
SMN is proposed to have specific functions in axon guidance and
synapse maturation which are independent of its role in snRNP
biogenesis [12,13,14,16,17,18,19,20]. Interestingly, SMN is found
not only in soma but also in axons [21] as well as at growth cones
in cultured motor neurons [22]. SMN localizes in granules that are
bi-directionally and rapidly transported [23,24]. In fact, SMN has
been shown to transport b-actin mRNA along the axon in
embryonic neurons in culture [19,25,26].
A role for SMN in axonal guidance seems to be relevant in
embryonic mouse motor neurons in culture, and in lower
vertebrates SMA models [18,19,20,23,27,28,29,30]. However, in
SMA mouse models most neuromuscular junctions (NMJs) are
normally innervated at early postnatal ages [31,32,33], suggesting
that in higher vertebrates in vivo neurite outgrowth and path finding
occur appropriately. On the other hand, in mouse models of SMA a
series of alterations at the level of the NMJ have been reported,
ranging from neurofilaments accumulation [32,34,35,36] and
immaturity of the postsynaptic site [32,33,35,36] to reduced
neurotransmitter release [35,36,37]. Some of these alterations have
been proposed to be due to a deficiency in axonal transport [38].
New findings supporting this hypothesis show that polymerized
tubulin levels are decreased in sciatic nerves from SMA-like mice,
while stathmin, a microtubule-destabilizing protein, is upregulated
in this mouse model [39].
Here, to better understand the alterations of neurotransmis-
sion at the NMJ we undertook a comprehensive functional and
morphological study in a SMA mouse model (SMND7, [40]). We
have explored the organization of sy n a p t i cv e s i c l e s( S V s ) ,a c t i v e
zones (AZs) and mitochondria within the terminal at P7 and P14,
the time points at which functional alterations have already been
reported [36]. In addition, we investigated the relationship
between SVs and the cytoskeleton (neurofilaments, actin and
microtubules). These observations have been combined with
electrophysiological estimates of the size and kinetics of the
readily releasable pool (RRP) of SVs. We present evidence that
SVs and AZs are clustered, the RRP size and the mitochondrial
pool size are reduced, and microtubules are highly disorganized
in SMN-deficient presynaptic terminals. Taken together these
results suggest that SMN is essential for the normal postnatal
organization and maintenance of the presynaptic motor
terminal.
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Synaptic vesicles are anomalously clustered and less
abundant in SMN-deficient motor terminals
To get insight into the postnatal presynaptic maturation process
in SMN-deficient terminals, we first examined SVs organization in
young mice (P7 and P14) in the TVA muscle, one of the most
affected in this disease [33,36]. We explored both the total area of
the terminal covered by SVs and the SVs spatial organization
using antibodies against the vesicular ACh transporter (VAChT),
conjugated with fluorescent secondary antibodies.
In wild-type (WT) mice, at the beginning of the NMJ postnatal
maturation period (first week of life), SVs were observed to be
grouped in small clusters (Fig. 1A), but by the second week, as WT
NMJs matured, SVs appeared to spread out and covered larger
areas of the terminal (Fig. 1C). In SMN-deficient terminals,
however, SVs remained clustered during this period (Fig. 1 B & D).
As the size of the NMJ was smaller in mutants (Fig. 1E), the
areas covered by SVs were normalized to the area of the
postsynaptic terminal. The total surface area of the terminal
covered by SVs was ,30% smaller in SMN-deficient terminals
(n=37 NMJs from 3 mice) than in WTs (n=38 NMJs from 3 mice)
at P7 (Fig. 1F; P,0.0001). At P14, this difference increased to
almost 50% (Fig. 1F; P,0.0001; WT: n=52; SMND7: n=58
terminals).
In addition, the size of SV clusters was smaller in mutants than
in WTs, both at P7 (,30%; P=0.02) and P14 (75%; P,0.0001)
(Fig. 1G). Remarkably, in mutants no change in cluster size, or in
the number of cluster per terminal, took place during the second
week of life, while in littermate controls the clusters size increased,
and the number of clusters diminished (Fig. 1G & H).
To test whether the clustering of SVs observed in the TVA
muscle of SMA mutants with anti-VAChT antibodies were also
seen with another vesicle marker, a double staining of SVs using
antibodies against VAChT, and the synaptic vesicle protein 2
(SV2) was performed. The vesicular fluorescence patterns
observed with anti-VAChT (green) were also seen with anti-SV2
(blue), both in WT, and in mutant terminals (Fig. S1). Quantitative
analysis of the immunofluorescence signals indicated that the
colocalization indexes of these two markers were ,0.9 in both
types of mice (Fig. S1). These data corroborate the smaller size of
the clusters in SMA mutant terminals, and rule out the existence of
an atypical vesicle population devoid of the vesicular transporter.
The synaptic vesicle pools and the vesicle release
probability are decreased in SMA
Electrophysiological recordings have shown that quantum
content of evoked End Plate Potentials (EPPs) is reduced in
SMA terminals [35,36,37]. This, combined with the reduced area
of immunolabeled SVs (Fig. 1), led us to examine the size of the
RRP of SVs (docked vesicles) by functional analysis.
Figure 2 shows representative WT (A) and SMND7 (B) EPPs
evoked by a stimulus train (20 Hz, 5 s) recorded in the TVA
muscle. During the initial part of the train, peak EPP amplitudes
follow a characteristic pattern consisting of a small amount of
facilitation followed by an exponential decline, corresponding to
the depletion of vesicles in the RRP [41,42]. Normally, these
phases are followed by a steady-state period (plateau) of matched
balance between vesicle consumption and refilling of release sites
(Fig. 2A). In SMA mutant terminals, however, rarely was there a
plateau and, instead, EPP amplitudes were highly variable
(Fig. 2B), suggesting the inability of mutant synapses to adjust
their neurotransmitter release to a constant rate or their low
release probability.
To examine the size of the RRP, the quantum content for each
stimulus was calculated by dividing the corrected mean EPP value
[43] by the mean miniature (mEPP) size. Then, the RRP was
estimated, by plotting quantum content against accumulated
quantum content (Fig. 2C & D), and drawing a straight line
through the declining phase [41]; the x-axis intercept of the fitted
points gives an estimate of the RRP size, with the assumption that
during the first 10–15 shocks most of the release comes from the
RRP. The mean RRP size was significantly reduced (by 35%) in
SMA mice (SMA: 515654; n=22 terminals, 6 mice; WT:
787667; n=23 terminals, 5 mice; P=0.003) (Fig. 2E). The
vesicle release probability (Pr) was also decreased in mutants
(0.04960.007, n=23 in 5 WT mice, and 0.03260.003, n=22in6
mutant mice; P=0.026) (Fig. 2F), suggesting that the reduced
quantum content [36] was due to a reduction in both the RRP size
and the Pr.
In addition, the total number of quanta released during the 5
second train was about 58% less in mutants (955688 quanta,
n=16) than in WT littermates (22586355 quanta, n=16)
(P=0.002), due to the lower quantum content and to a higher
level of synaptic depression in mutant terminals, indicating that it
also existed a reduction in the recycling pool (RP) of SVs.
Mobilization of vesicles to the readily releasable pool is
not altered in SMA
The refilling of the RRP takes place by mobilization of new
vesicles from the recycling pool (RP) and/or by the recycling of
vesicles from nearby regions after undergoing a previous round
of exocytosis. A variation of the Elmqvist & Quastel method
[41] was used to estimate the kinetics of the RRP depletion and
refilling (see methods and [42]). When we compared the time
constant of the RRP exhaustion in WT and mutants
(discontinuous blue line in Fig. 2I & J), no significant difference
was found (WT: 0.960.1 s; n=16 terminals, 3 mice ; SMND7:
1.160.1 s; n=16 terminals, 4 mice; P=0.12) (Fig. 2G);
similarly, the mean half-time taken for vesicles to refill the
RRP (discontinuous red line in Fig. 2I & J), was not significantly
different in mutants (1.460.1 s, n=16)thaninWTs (1.260.1,
n=16; SMND7; P=0.17), (Fig. 2H). These data suggest that the
depletion kinetics of vesicles at AZs, and the availability of new
vesicles for successive rounds of exocytosis were not slowed in
mutants.
Mitochondria are diminished but well co-localized with
synaptic vesicles in SMA
Some of the roles of presynaptic mitochondria are to provide
ATP for synaptic transmission, ion pumps, and assembly of actin
cytoskeleton involved in the clustering of SVs and mitochondria
themselves. Another role of mitochondria is regulation of
intraterminal Ca
2+ levels, providing an especially important
buffering action during trains of action potentials. Therefore, a
reduction in the number of mitochondria, alteration in their
spatial distribution, or impairment of their functional capacities,
may decrease their Ca
2+ buffering capability and produce toxic
Ca
2+ overloads. To assess whether an alteration in mitochondria
spatial distribution, or density was present in SMN deficient
terminals, the TVA muscle was incubated with mitotracker
(400 nM), a cell-permeant probe that is sequestered by functioning
mitochondria and retained during cell fixation [44].
Figure 3A-D (central panels) shows representative examples of
the distribution of mitotracker labeled mitochondria in motor
terminals. Quantification of the number of mitotracker spots per
terminal showed no significant differences between WT and
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PLoS ONE | www.plosone.org 2 October 2011 | Volume 6 | Issue 10 | e26164Figure 1. Synaptic vesicles in motor terminals of SMND7 mice are reduced and anomalously distributed. Representativeenfaceviews of NMJs
from the TVA muscle stained with BTX-Rho (red), which binds specifically to postsynaptic AChRs, and anti-VAChT (green), which labels synaptic vesicles.
Images are Z-stack projections. A&B .Terminals of WT and SMND7 mice, respectively, at P7. C&D .At P14, the postsynaptic apparatus and SVs appeared
less mature in mutants (D) than in WTs (C), and SVs in mutants appeared in compact clusters while they distribution in WT terminals were predominantly
diffuse. E. Mean postsynaptic areas were significantly smaller in mutants than in WT terminals, both at P7 and P14. F. The area of VAChT stained vesicles
(normalized to the postsynaptic size) was smaller in SMND7 than in WT motor terminals. G. The mean size of vesicle clusters in SMND7 was smaller than in
WT at P7 and P14. H. The mean number of SV clusters was larger in SMND7 terminals at P14. Scale bar: 5 mm; *: P,0.05; **: P,0.005; ***: P,0.0005.
doi:10.1371/journal.pone.0026164.g001
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23.563.1, n=19 terminals) (P=0.9). The total area stained by
mitotracker per terminal, however, was about half in mutants
(19.462.7 mm
2; n=20) as compared to WT terminals
(38.864.9 mm
2; n=22; P=0.002). Normalization of these areas
to postsynaptic surface area also gave significantly smaller values in
mutants (WT: 0.2960.03; mutant: 0.1960.02; P=0.01). This
difference was mainly due to the smaller size of the mitotracker
Figure 2. RRP and Pr are reduced in motor terminals from the SMND7 TVA muscle. A & B. Representative traces of EPPs during 5 s trains
of stimuli at 20 Hz in WT and SMA mice (P14), res pectively. C&D . Examples showing the technique for the estimation of RRP size by the x-intercept
of the fitted points. E–H. Mean RRP size, vesicle release probability, depletion time constant, and refilling half time, in WT and SMND7 terminals. I&J .
Representative examples for the estimation of the kinetic properties of the recruitment process in WT and SMND7. * P,0.05; **: P,0.005.
doi:10.1371/journal.pone.0026164.g002
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PLoS ONE | www.plosone.org 4 October 2011 | Volume 6 | Issue 10 | e26164Figure 3. Mitochondrial density in SMA presynaptic terminals is reduced. A–D. The upper panels (A & C) show Z-stack projections while the
lower panels (B & D) show single confocal sections. The staining from left to right are: BTX-A647 (grey), SVs (green), mitotracker (red), merge of SV and
mitochondria. Data are from the TVA muscle (P14). E. Nearest neighbor distributions of SV clusters and mitochondrial regions (calculated from their
respective center of mass), in WT and mutants terminals. F. Relationship between mean areas covered by SV and mitochondria in WT (blue symbol)
and SMND7 (red symbol) terminals. Scale bars A-D: 5 mm; insets: 600 nm.
doi:10.1371/journal.pone.0026164.g003
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2, n=360 spots; mutant: 0.8960.1 mm
2,
n=214 spots. P=0.03) in mutants.
Next, we explored the spatial relationship between mitotracker
spots and SV clusters. In most cases, as in the illustrated examples,
mitochondria (red) appeared near SV clusters (green) in both WT
(Fig. 3A & B) and mutant terminals (Fig. 3C & D). Moreover, in
many cases a core of mitochondria was clearly surrounded by a
SV rim (Fig. 3A–D, right panels), reminiscent of the donut-like
structures described in the calyx of Held [45,46]. Quantification of
this co-clustering was done by measuring the nearest-neighbor
distances between SV clusters and mitochondria spots. Nearest-
neighbor distances were determined by fitting each of the red and
green spots to a 2D Gaussian distribution, and using the peak (x,y)
of each distribution. The results in nine mutant terminals (202
measurements) and 13 WT terminals (282 measurements), showed
that in mutants SVs and mitochondria were, as in controls, closely
associated (Fig. 3E). Even more, the percent of red-green spots
nearest distances within 1 mm were larger in mutants (41%) than
in WT (31%) (P=0.0006), as expected for the smaller sizes of SV
and mitochondria cluster in mutants (Fig. 3F).
Taken together, these results show that in mutant terminals the
close spatial relationship between mitochondria and SV clusters
was not lost, but revealed a reduction in the amount of functional
mitochondria.
Active zones are reduced and clustered in SMA
Given the reduction on the RRP size found in mutants (Fig. 2),
we wondered whether the number of AZs per terminal was
reduced in comparison with littermate controls. To identify AZs,
an antibody against bassoon, a scaffolding protein of AZs [47], was
used in the TVA muscle.
Typically, AZ number and distribution change during the
postnatal maturation period. Fig. 4A shows, at P7, two typical
examples of the lower abundance and differential distribution of
bassoon spots in mutant (lower panel) compared with WT (upper
panel) terminals. At P14, these apparent differences were even
clearer. In the examples shown in Figure 4B the total number of
bassoon spots counted in each nerve terminal were 273 in the WT
(central upper panel) and 139 in the mutant (central lower panel),
which resulted in 1.29 and 0.69 bassoon spots/mm
2, respectively.
On average, at this age, the number of bassoon spots per terminal
was 208620 (n=20), in WT and 102612 (n=15), in mutants
(Fig. 4D) (P=0.0002), and their density 1.160.1 bassoon spots/
mm
2 in WT, and of 0.760.1 in mutants (Fig. 4E) (P=0.009). In
addition, while in WTs bassoon spots appeared regularly
distributed within the terminal (cf., Fig. 4B, central panel), in the
mutants spots were apparently grouped and co-clustered with SVs
(cf., Fig. 4B, lower central and right panels). Figure 4C illustrates
bassoon spots in another mutant terminal, now in a planar
projection; bassoon spots were clearly associated with SV clusters
and, in some cases, a SV cluster was surrounded by a group of
bassoon spots (Fig. 4C, inset).
The spatial distribution of the bassoon spots was quantified by
nearest neighbor analysis performed on whole terminals. Fig. 4F
shows the distance between bassoon spots (centers of 2D gaussian
fits) from three WT (left) and three mutant (right) terminals. In
both, the shape of the distribution were quasi normal-shaped. The
average nearest neighbor separation in WTs (876627 nm; n=694
particles) was not significantly different (P=0.27) to that in
mutants (921629 nm; n=399 particles). These results indicate
that in mutants AZs were regularly spaced but they were missing
in some areas, following the anomalous clustering of SVs within
the terminal.
Neurofilament accumulation follows synaptic vesicle
reduction
NF accumulation is a hallmark of many neurodegenerative
diseases [48], including SMA mouse models [32,33,34,35,36].
Therefore, to better understand the pathophysiology of this
process the spatial distribution of the NFs, and the relationship
between NFs and the clusters of SVs were studied in the TVA
muscle during the first and second week of postnatal life.
Interestingly, at P7, SV aggregates localized along the NF
trajectory, both in WT and mutant terminals (Fig. 5A & B). In
many cases, NFs ended in loop-like structures about 1.35 mmi n
diameter (arrows), which hosted clusters of SVs (Fig. 5A & B,
insets). These structures, which are characteristic of cytoskeletal
immaturity [49,50], were equally frequent in mutant and WT
terminals at this age (mean number of loops/terminal: 4.460.6,
n=38 versus 460.4, n=37; P=0.45).
At P14, the spatial localization of SVs along the NF trajectory
persisted in mutants (Fig. 5D) while it was less obvious in WT
terminals (Fig. 5C). Also, at this age the loops were rare (0.960.2
loops/terminal, n=52) and small (1.260.1 mmi nd i a m e t e r ,n=20) in
WT terminals (Fig. 5C, inset), while they were significantly more
frequent (2.960.3 loops/terminal, n=48) (P,0.0001), and enlarged
(1.760.1 mmdi a m e t e r ,n=20) (P=0.0014) in mutants (Fig. 5D, inset).
The mean area of the terminal occupied by NFs was 1.7-fold
higher in mutant than in WT terminals at P14 (P,0.0001; n=38)
but was not significantly different at P7 (Fig. 5E). Given the
apparent reduction in SVs at this age, the surface ratio between
NFs and vesicles was ,3.5-fold larger in mutants than in controls,
while it was only 1.5-fold larger at P7 (Fig. 5F).
These results indicate that NF postnatal maturation was
interrupted in mutants and, in addition, suggest that the amount
of NF protein was not down regulated as in controls, resulting in
their accumulation during the second postnatal week. The data
also show that NF accumulation followed the decrease in SVs.
F-actin and synaptic vesicles are closely associated in
SMA
Filamentous actin (F-actin) is a prominent cytoskeletal element
in nerve terminals. The F-actin-based network [51] may
participate in creating a scaffold for SV clustering, and/or in
supporting ordered vesicle mobility. In addition, it has been
suggested that F-actin anchors synaptic vesicles to AZs by a labile
link formed with synapsin, a vesicle protein [52,53].
SMN deficiency produces defects in beta-actin mRNA axonal
transport, and a decrease in actin protein content in growth cones
of motoneurons in culture [19]. We explored F-actin content and
distribution in presynaptic TVA motor terminals of SMA mutant
mice. F-actin was revealed by binding to fluorescent Phalloidin-
Alexa 647, which binds to all isoforms of F-actin but not to
monomeric actin [54]. In addition, to gain insight into the role of
F-actin in the organization of SVs, the distributions of F-actin
relative to SVs were also examined.
F-actin was localized in the sub-plasmalemmal region and deep
into the cytoplasm forming a thin network. Figure 6A shows a WT
terminal with F-actin labeled with phalloidin (upper panel), SVs
labeled with VAChT antibodies (green), and postsynaptic
receptors labeled with BTX-Rho (red, lower panel). In Figure 6B
a typical terminal from a mutant mouse is shown (left panel,
phalloidin image; central panel, anti-VAChT and BTX-Rho
merged). In some cases, F-actin was also clearly visualized in the
axon (Fig. 6B, arrow in right panel). In WT and mutant mice, F-
actin filaments run parallel to the major axis of the terminal and
SV clusters are positioned along them.
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PLoS ONE | www.plosone.org 6 October 2011 | Volume 6 | Issue 10 | e26164Figure 4. AZs in SMA motor terminals are reduced but well associated to SV clusters. A. NMJs at P7 labeled with anti-bassoon (left), and
BTX-Rho (right), in a WT (upper panels) and mutant (lower panels) muscle. In WT bassoon spots are abundant throughout the terminal, while in the
mutant spots are scarce. B. NMJs at P14, bassoon and postsynaptic receptors labeled as in A, SVs labeled with anti-VAChT (right), in a WT (upper
SMN Is Essential for Motor Terminal Maturation
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visualized in transverse single confocal slices. Figure 6C (WT) and
6D (mutant) show two representative examples showing F-actin
surrounded SV clusters forming ring-like structures, similar to
actin rings described in the lamprey reticulospinal giant synapse
[55]. Interestingly, the diameter of F-actin rings surrounding SVs
were apparently smaller in mutant than in WT terminals, as could
be appreciated by their respective line intensity profiles across SVs
and phalloidin loops (Fig. 6E). However, these structures were not
visualized frequently enough for statistical analysis. Thus, the
percentage of the terminal area occupied by phalloidin, normal-
ized to the postsynaptic area, was quantified (Fig. 6F). In WT
mice, although the area of the terminal covered by phalloidin was
apparently larger than in mutants (WT: 4169%, n=6 terminals;
mutants: 3464%, n=6 terminals), this difference did not reached
statistical significance (P=0.5).
Severe alteration of microtubules organization in SMA
Microtubules provide rails for the transport of organelles by
means of microtubule-associated motor proteins. To examine the
microtubule organization in the nerve terminal of controls and
SMND7 mutants an acetylated tubulin antibody, which marks
polymerized tubulin, was used.
In axons from the TVA muscle, no difference in tubulin
distribution between WT and mutant mice was observed at P9-
P11, suggesting that axon guidance and fasciculation apparently
were not affected in SMND7 mutant mice (Fig. 7A). In the
presynaptic terminals, however, the organization of polymerized
tubulin differed in WT and mutant mice (Fig. 7B). In most WT
terminals, microtubules appeared grouped in thick and thin
bundles (left panel). Nevertheless, in most mutants microtubules
appeared scattered all over the terminal, instead of fasciculated,
and with a punctuate appearance (right panel). We quantify the
percent of terminals containing branched-like, scattered-like, and
mixed patterns (Fig. 7D). In WT mice, the branched-like pattern
was the most frequent (74%), and no scattered-like ones were
observed. In mutants, on the other hand, the majority of terminals
showed a mixed pattern (,54%), and only 18% showed a normal
branched pattern.
Quantification of the tubulin stained area per terminal gave no
significant differences between controls and mutants
(81.0963.81 mm
2, n=32 terminals, vs. 76.4963.72 mm
2, n=33;
P=0.39). However, when these values were normalized to the
postsynaptic areas, mutants showed to have a relative greater
amount of microtubules than controls (0.4460.02 vs. 0.3760.02),
(P=0.0083) (Fig. 7E).
To explore whether the anomalous organization of microtu-
bules in SMND7 terminals was due to the immaturity of the
presynaptic terminal, we looked at the distribution of microtu-
bules at an early age (P4). Interestingly, microtubules appeared
scattered and punctuated in WT terminal at this age (Fig. 7C,
left panel), similar to the pattern in mutants from P4 to P11
(Fig. 7 B & C, right panels), suggesting a defect in the
rearrangement of microtubule architecture during the postnatal
period in mutants.
The above results, together with the other presynaptic defects in
the TVA muscle, raised the question of how specific this
phenotype is. Therefore, we explored the NMJs in the LAL, a
muscle in which SMND7 postsynaptic sites have been described to
mature almost at the same pace as in control mice [33], with the
exception of NMJs in the caudal band which are more vulnerable
to low SMN levels [33,36]. In the rostral band, at P7, postsynaptic
area (Fig. 8 B), SV content (Fig. 8C), and SV cluster size (Fig. 8D)
were not different in WT and mutant mice (P=0.74 and P=0.50;
n=21 & 24 terminals, respectively), while the last two parameters
were significantly reduced in mutants at P14 (Fig. 8C & D),
(P=0.0003 and P=0.006, respectively). In the caudal part,
however, vesicle parameters were already decreased at P7 and
did not increase with age (Fig. 8F & G). Interestingly, evoked
neurotransmitter release (quantal content) was not statistically
different in control and mutants (WT: 10.2160.74 and mutants:
7.4861.22; P=0.07; Fig. 8H) in the rostral part of the muscle at
P14. These findings also show that the defect in presynaptic
differentiation is not secondary to a blockade of postsynaptic
differentiation.
Discussion
The mechanisms underlying the postnatal maturation of pre-
and postsynaptic specializations are finely controlled to assure
reliable spatial and temporal transmission of information in and
from the nervous system. At the end of the synaptic maturation
process optimal juxtaposition of postsynaptic receptors and
presynaptic neurotransmitter release sites is achieved. From the
presynaptic side, the key elements to regulate are the position and
density of proteins and organelles within the terminal. How this
process is controlled, however, remains obscure. Here, we report
that SMN-deficient mice present presynaptic defects in SVs,
mitochondria, AZs, NFs and microtubules, as well as in
neurotransmission, with a pattern compatible with a deficiency
in presynaptic differentiation.
In the TVA muscle of SMN-deficient mice SVs remained
clustered at P7, contrary to what happened in control mice where
SVs dispersed and occupied larger areas of the terminal. In
addition, SMN-deficient motor nerve terminals stopped accumu-
lating SVs at P7, resulting in a 50% decrease in vesicles in mutants
compared to controls at two week of age (Fig. 1F). This last finding
was in agreement with the decrease in size of the synaptic vesicles
pools found electrophysiologically at this age (Fig. 2). Strikingly, in
the rostral band of the LAL these alterations appeared about a
week later (Fig. 8). In the Tibialis anterior (TA) and in the Extensor
digitorum longus (EDL) muscles two different ultrastructural studies,
in the same SMA mouse model, also found a decrease in SVs
density [35,56]. Conversely, in the diaphragm no significant
difference in vesicle number has been found [57]. Moreover, the
size of the pool of SVs ready to be released (RRP) has been
reported to be comparable in SMND7 and littermate controls in
the EDL (Ling et al., 2010), a mildly SMA affected distal muscle.
However, here we found that the RRP size was decreased in the
TVA in mutant mice (Fig. 2), in agreement with the ultrastructural
observation of a similar decrease in docked vesicles in nerve
terminals from TA muscle [35]. Therefore, there seems to exist a
correlation between the degree of muscle pathology and the
variability in SV content.
panels) and mutant (lower panels) TVA muscle. In WT bassoon spots appear distributed evenly throughout the terminal, while in the mutant spots
are clumped in groups that co-localize with SVs. C. Planar projection of a mutant NMJ stained with anti-bassoon (magenta), BTX (grey) and anti-
VAChT (green) showing clustering of SVs and bassoon spots. D–E. Mean number of bassoon spots per terminal (left graph), and per mm
2 (right graph)
in WT (n=15) and SMND7( n=20) fibers. F. Distribution of bassoon spots interdistance (nearest neighbors) in three WT (n=694) and three SMND7
(n=399) fibers. Scale bars: 5 & 1 (insets) mm. ** (P=0.009); *** (P=0.0002).
doi:10.1371/journal.pone.0026164.g004
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PLoS ONE | www.plosone.org 9 October 2011 | Volume 6 | Issue 10 | e26164In the present experiments we also found a ,50% reduction of
total active mitochondrial surface in mutant presynaptic terminals
(Fig. 3), with no apparent alteration in their spatial organization
close to SV clusters. Previous evidence also suggests that
mitochondrial defects are present in SMA nerve terminals. For
example, in the TA muscle mitochondrial density is reduced by
half in mutants while their morphology is normal [35,20]. In the
diaphragm, however, presynaptic mitochondria are smaller in
mutants than in wild-type littermates, while no differences are
found at the postsynaptic site [32]. In the TVA, the amount of
Ca
2+-dependent asynchronous neurotransmitter release during
prolonged stimulation is increased, which might suggest an altered
regulation of bulk [Ca
2+] by the mitochondria [36]. Mitochondrial
dysfunction has also been reported when Smn is knocked down in
cultured neuronal cells, a cell model of SMA [58]. Mitochondrial
defects have been demonstrated in other motor neuron diseases,
including ALS [59,60] and Spinal and Bulbar Muscular Atrophy
[61].
Beside the reduction and clustering of SVs and mitochondria in
SMA mutant terminals, we also found a reduction in the density of
AZs (visualized with anti-bassoon antibodies), together with an
alteration in their distribution (Fig. 4). This, together with the
decrease in the RRP size (Fig. 2), may explain the drop in
neurotransmitter release as evidenced by estimation of the quantal
content [35,36]. A smaller number of AZs might be caused by a
deficiency of presynaptic P/Q- and N-type voltage-dependent
calcium channels in the nerve terminal [62,63]. In motoneurons in
culture from SMN deficient embryos, N-type calcium channels
have been described to be diminished at growth cones [64]. It
could be of interest, therefore, to explore this possibility at motor
terminals of postnatal mutant mice in the future.
It is interesting to note the parallels between the decrease in
SVs, mitochondria and AZs in SMN deficient nerve terminals
(Figs. 1, 3 & 4). The association between mitochondria and SVs is
relevant for ATP-dependent functions such as refilling of SVs with
neurotransmitter. On the other hand, the close relationship
between AZs and SVs is essential for the efficient refilling of the
release sites. In addition, the proximity of mitochondria to the
plasma membrane may also support SV cycling. Thus, in SMN
deficient terminals, the reduction of these organelles could be
partially responsible for the functional impairment of the synapse.
It is difficult to discern, however, whether the decrease in
mitochondrial density is a consequence of the decrease of the
SV pools. Other possibilities are also feasible, for example, a
malfunction of the control mechanisms that maintains an
appropriate pool of mitochondria within the presynaptic terminal.
The interactions of mitochondria and SVs with the cytoskeleton
are crucial for localization and maintenance of these organelles at
their sites of action. For example, the subcellular localization
(docking process) of mitochondria is likely based on F-actin
filaments [65,66], in turn regulated through the RhoA/formins
pathway [67]. Finally, a deficiency in the microtubule-based
anterograde transport of mitochondria, SVs and AZ precursors, is
also plausible. A fault in the microtubule network itself, or in the
motor proteins responsible for those cargos, may cause this
phenotype. In support of this possibility, it has recently been
reported that there is a decrease in polymerized tubulin at distal
axons of SMN deficient terminals and less amount of mitochon-
dria in the motor neurons [39].
For all these reasons we also studied the cytoskeleton (NFs, actin
filaments, and microtubules) in SMND7 motor terminals.
Previously, it has been reported that NFs accumulated in motor
axons and in the terminals of SMA mouse models
[32,33,34,35,36]. The importance of NF accumulation in the
SMA pathogenesis is difficult to determine. NF overpacking may
impair axonal transport of vesicles to terminals. However, we
found that SV content in nerve terminals of the TVA muscle was
already reduced at one-week of age (Fig. 1F), a time at which
abnormal NF accumulation was not apparent (Fig. 5E), suggesting
that NF accumulation is a late event in the disease progression. In
addition, we also found a marked tendency of intraterminal NFs to
end in balls in SMA mutants at P14 (Fig. 5D), a sign of immaturity
that suggests impairment in NF assembly and turnover.
A defect in axonal transport in SMN-deficient animal models
cannot, nevertheless, be discarded. SMN has been implicated in
the axonal transport of mRNA of beta-actin and other cargoes
necessary for motor neuron integrity and function [19,26]. In
nerve terminals, F-actin is known to play important roles in SV
recycling [55,68] and, probably, in the tethering of SVs at AZs
[69]. Therefore, even a small decrease in actin content in SMA
motor terminals (Fig. 6), may affect one or more functions related
to the transport or the stability of these organelles. Although this
hypothesis is attractive, however, a newly generated motor neuron
specific beta-actin conditional knock-out mouse does not present
an altered phenotype at the NMJ [70].
Recently, it has been reported that microtubule polymerization
is disrupted in Smn-deficient NSC34 cells in culture, that the
amount of acetylated tubulin is about one third of controls in
sciatic nerves of SMA mice and that the number of axonal
microtubules per axon is reduced by 25% in mutant mice [39]. We
here found that the presynaptic motor terminals of SMND7 mice
show a reduction and an abnormal distribution of microtubules
(Fig. 7), compatible with the arrest of postnatal maturation at the
presynaptic terminal. The scattering of microtubules in mutant
terminals might, in turn, contribute to the delayed organization of
the synaptic organelles.
In summary, our data show that SMN is essential for postnatal
maturation of SVs, AZs, mitochondria and the cytoskeleton at the
motor nerve terminal. We also suggest that this disruption in the
presynaptic architecture might limits synaptic transmission in most
affected muscles. These results, together with data from others
showing delay in the maturation of the postsynaptic terminal,
failure of muscle fiber growth, and a decrease in synaptic inputs to
spinal motor neurons [37,71,72], support a possible role of SMN
in neuromuscular development. Future investigations in this
direction, therefore, may help to better understand the patho-
physiology of this disease.
Materials and Methods
Mouse model
Mouse lines were kindly provided by Dr. A. Burghes.
Experimental mice were obtained by breeding pairs of SMA
Figure 5. NF accumulation in SMA terminals occurs at a late stage of the disease. A–D. Left panels: NF staining (magenta) showing ring-
like structures. Discontinuous lines (Panel B) mark dim NF labeling. Right panels: Merged images showing the spatial relationship between SVs and
NFs. Note that at P7 SV clusters were near NFs, either inside the loops (arrows) or along their paths (A & B), while SVs were around the compact ring-
like structures, at P14. Data are from TVA muscles of WT and SMND7 mice. Scale bar: 5 mm. Images are Z-stack projections. E. NF area, normalized to
postsynaptic area, in P7 and P14 WT and mutant terminals. F. Surface ratio between NFs and SVs in WT and mutants at both ages. *: P,0.05;
**: P,0.005; ***: P,0.0005.
doi:10.1371/journal.pone.0026164.g005
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PLoS ONE | www.plosone.org 10 October 2011 | Volume 6 | Issue 10 | e26164Figure 6. F-actin and SVs are closely associated in SMA motor terminals. Data are from the TVA muscle (P14) A–B. Representative examples
of the distribution of F-actin (grey) in a WT (A) and a mutant (B) terminal. The same terminals are also shown stained for SVs (green) and postsynaptic
receptors (red). Arrow in the right panel of B points to actin in the axon. C–D. Phalloidin (grey), SVs (green), and AChRs stained with BTX-Rho (red),
showing the organization of actin around SV clusters. Image in C is from a SMND7 terminal and in D from a WT terminal. E. Intensity profiles across
actin loops and SV clusters showing the reduced diameter and thickness of the loop in mutants. F. Phalloidin areas in WT and mutant terminals were
not significantly different (P.0.05). Scale bars: A & B: 5 mm; C & D: 2 mm.
doi:10.1371/journal.pone.0026164.g006
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PLoS ONE | www.plosone.org 11 October 2011 | Volume 6 | Issue 10 | e26164Figure 7. Microtubules are immature and more abundant in SMA presynaptic terminals. A. Representative images from WT (left) and
SMND7 (right) axon microtubules in TVA muscles at P11 apparently showing no alterations. Scale bar: 10 mm. B–C. Typical distribution of
microtubules in WT and mutant nerve preterminals, at P11 (B) and P4 (C). Scale bars: 5 mm. D. Percentage of presynaptic terminals showing
microtubules in a fasciculated-like, scattered-like, or mixed pattern, at P11. E. Microtubule area in the presynaptic terminal, normalized to the
postsynaptic surface, was significantly larger in SMND7 than in WT mice. **: P,0.005.
doi:10.1371/journal.pone.0026164.g007
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PLoS ONE | www.plosone.org 12 October 2011 | Volume 6 | Issue 10 | e26164Figure 8. Selective alterations of SVs in motor terminals from the LAL muscle. A. Representative images of pre- and postsynaptic
characteristics of NMJs in the LAL muscles of WT (upper panels) and SMND7 (lower panels) mice at P14. Postsynaptic terminals were labeled with
BTX-Rho (red) and presynaptic vesicles with antibodies against VAChT (green). Note the clustering of SVs despite the mature appearance of the
postsynaptic side in the SMND7 terminal. Scale bar: 5 mm. B–G. Mean postsynaptic area (B & E), SV area (C, F), and cluster area (D, G) in SMND7 and
WT terminals, from rostral (B–D) and caudal (E–G) divisions of the muscle. Note that the area of vesicles and the cluster sizes were not significantly
different in the rostral part of SMND7 terminals at P7, while these parameters were significantly reduced at P14. However, in the caudal part SVs
deficiencies in SMND7 terminals were evident since P7 (n=16 WT terminals and n=15 SMND7 terminals). *: P,0.05; **: P,0.005; ***: P,0.0005.
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background. Identification of wild-type (WT) and SMA mice
(Smn-/-; SMN2; SMND7) was done by PCR genotyping of tail
DNA as previously described [40]. All experiments were
performed according to the guidelines of the European Council
Directive for the Care of Laboratory Animals.
Muscle preparation
Mice were sacrificed by CO2. The Levator auris longus (LAL) and
Transversus abdominis (TVA) muscles were dissected with their nerve
branches intact and pinned to the bottom of a 2 ml chamber, over
a bed of cured silicone rubber (Sylgard, Dow Corning Corp.).
Preparations were continuously superfused with physiological
solution (in mM): 125 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2,2 5
NaHCO3 and 15 glucose, continuously gassed with 95% O2 and
5% CO2 (pH: 7.35). Electrophysiological recordings were
performed at room temperature (22–23uC).
Intracellular recording
Standard electrophysiological techniques were used to record
miniature (mEPPs) and evoked end-plate potentials (EPPs) using
conventional microelectrodes (R=10-25 MV fill with 3 M KCl) as
described previously [36]. Recordings were done in the TVA
muscle from control and SMA mice at P14-15 days of age. Nerve
stimulation was carried out by a suction electrode. The stimulation
consisted of square-wave pulses of 0.2-0.5 ms duration and 2–40 V
amplitude, at variable frequencies (0.5–20 Hz). Muscle contrac-
tions were blocked with m-conotoxin GIIIB (2–4 mM, Alomone), a
specific blocker of skeletal muscle voltage-gated sodium channels.
Quantum contents during a train were plotted against time, and
fitted to a sequential model of release [42] that assumed that all
release on the first shocks came from the RRP, which is depleted
along an exponential time course, and that the refilling of the RRP
rose sigmoidally to a plateau level. The probability of release (Pr)
was calculated by dividing the first EPP quantal content by the
RRP size.
Immunohistochemistry
Whole-mount dissected muscles were incubated for 30 min in
Ringer solution saturated with 95% O2/5% CO2 before fixation
in 4% paraformaldehyde. Later, muscles were bathed in 0.1M
glycine in PBS for 20 min, then permeabilized with 1% (v/v)
Triton X-100 in PBS for 30 min and incubated in 5% (w/v) BSA,
1% Triton X-100 in PBS for 2 h. Samples were incubated
overnight at 4uC with the primary antibodies of interest (see
below). The following day muscles were rinsed for 1 h in PBS
containing 1% Triton X-100, incubated for 1 h both with the
corresponding secondary antibodies and 10 ng/ml rhodamine-
BTX or BTX-Alexa 647 (BTX-A647) (Molecular Probes) and
rinsed again with PBS for 90 min. Presynaptic terminals were
labeled with antibodies against the vesicular acetylcholine
transporter (VAChT; 1:500, Synaptic System), the synaptic vesicle
2 protein (SV2; 1:500, Developmental Studies Hybridoma Bank),
neurofilaments (NF; 1:750, Millipore), acetylated tubulin (1:1000,
Sigma) and Bassoon (1:100, Stressgen). The preparations were
incubated with fluorescent secondary Alexa antibodies (1:500,
Invitrogen). Finally, muscles were mounted with slowfade medium
(Sigma).
Mitochondrial labeling
Fresh tissue was incubated with Mitotracker Orange (Invitro-
gen), a mitochondrion-selective stain that is concentrated by active
mitochondria and retained well during cell fixation, at final
concentration of 400 nM. The muscle was then washed, fixed and
processed for additional labeling of other organelles.
Actin labeling
Fixed (4% PFA) and permeabilized (1% Triton X-100) muscles
were incubated with the actin dye Phalloidin-Alexa647 (Invitro-
gen) at a working concentration of 170 nM. Later, the preparation
was washed and mounted with slowfade medium.
Image acquisition and analysis
Muscles were imaged with an upright Olympus FV1000
confocal laser scanning microscope, equipped with three excitation
laser lines (argon-krypton laser with 488, 561 and 633 nm
excitation lines). During image acquisition, an alternating
sequence of laser pulses was used for activation of the different
fluorescent probes. Images were taken using a 63x oil-immersion
objective with a numerical aperture of 1.4. Images from wild-type
and mutant littermate preparations were taken with similar
conditions (laser intensities and photomultiplier voltages) and,
usually, during the same day. For analysis, only fully occupied
terminals were considered [33].
Morphometric analysis of the fluorescently labeled structures
was performed offline with ImageJ (W. Rasband, National
Institutes of Health, Bethesda, MD; http://rsb.info.nih.gov/ij/).
Postsynaptic terminal, SVs and NFs areas were determined
automatically, by finding outline masks based on brightness
thresholding, from maximal projected confocal images.
All statistics given as mean 6 standard error of the mean, unless
stated otherwise. Differences between groups were tested using the
t-test (2 tails).
Supporting Information
Figure S1 VAChT and SV2 colocalize in SMA synaptic
vesicles. A & B. Examples of WT and SMND7 terminals at P14
from TVA muscles. Images are Z-stack projections. Scale bar:
5 mm. C. Quantification of colocalization by Pearson coefficient
showed no significant difference between SMND7( n=9 terminals)
and WT (n=4 terminals) mice (P=0.78).
(TIF)
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